A New Job for Gilotrif
The US Food and Drug Administration has approved Gilotrif (afatinib) to treat squamous cell lung cancer.
Lung Cancer Rx Might Outperform Chemo
When you're sick, you may feel like the immune system is a weak tool for protecting the body. But new evidence is showing how medications might activate the immune system to treat a very serious illness — lung cancer.
Trial on Bristol-Myers Squib Drug Stopped Early
Bristol-Myers Squibb Company (NYSE:BMY) today announced that an open-label, randomized Phase 3 study evaluating Opdivo versus docetaxel in previously treated patients with advanced, squamous cell non-small cell lung cancer (NSCLC) was stopped early.
Good To The Bone
When lung cancer starts to spread, it often goes to the bone. This is the site of metastasis (spread) for other cancers as well. A comparison of bone medications found one to be superior.
Lung Cancer Has a New Enemy
One of the most deadly illnesses current and past smokers can face is squamous cell lung cancer. Until now, though, no drugs have targeted the gene mutations that cause this disease
Saving the Lives of Heavy Smokers
Lung cancer is most commonly detected with a chest X-ray. This standard technique misses a number of early cancers, though. A study shows another technology is not only a better screening tool, but can save the lives of smokers.
A Whiter Shade of Pale
With the temperatures heating up, so does the desire to spend time outdoors soaking up the rays. With talk about irreversible skin damage, including cancer and premature aging, most of us have made more of an effort to protect our skin from the sun's harsh rays.